Even with a single point mutation, correcting enzyme dysfunction is inherently challenging
Error two: Lyophilized peptides occupy minimal volume before reconstitution
The TRIUMPH program includes seven other Phase 3 trials (TRIUMPH-1 general obesity 80 weeks, TRIUMPH-2 obesity+T2D, TRIUMPH-3 obesity+CV disease, plus T2D, OSA, and CVOT) with readouts expected during 2026
Liver protection Besides, glutathione can also participate in carboxymethyl and transpropylamino reactions, thus achieving the physiological effect of protecting liver function [1][2]
uterine artery embolization to disrupt blood supply to the fibroid
This amylin analog peptide addresses this issue through molecular modifications that enhance stability and extend its half-life, allowing for convenient once-weekly subcutaneous administration in clinical protocols